Everything below concerns 冻干粉. We keep the language plain, cite what the science says, and separate well-supported claims from open questions.
Updated 2026-02-20. Numbers and descriptions here follow the published literature rather than marketing material.
The compound first appeared in the scientific literature as an investigational agent for type 2 diabetes. Clinical development proceeded through phase 1, phase 2, and phase 3 programs that measured glycemic control as a primary endpoint while recording body weight as a secondary outcome. Regulatory approval in the United States followed in 2022 for glycemic control, and a separate indication for chronic weight management was added later. Subsequent trials have examined cardiovascular outcomes in adults with elevated cardiovascular risk. Debates continue over how much of the observed effect derives from each receptor arm.
Structural work on the molecule centers on a C20 fatty diacid moiety attached through a linker to the peptide backbone. This side chain promotes reversible binding to serum albumin, which slows renal clearance and supports a prolonged action profile. The peptide backbone incorporates aminoisobutyric acid substitutions that limit recognition by digestive enzymes. Together these modifications produce a molecule that is stable enough for subcutaneous delivery but still dependent on careful manufacturing control. Analytical characterization of the active pharmaceutical ingredient typically follows the conventions used for other synthetic peptides.
Clinical research programs have evaluated tirzepatide in adults with type 2 diabetes and in adults with obesity or excess weight. Trials generally reported reductions in glycated hemoglobin and body weight across treatment periods of several months. Since these studies enrolled defined populations under controlled conditions, the findings describe group averages rather than individual outcomes. Open questions include the durability of effects after treatment stops, variation among subgroups, and the long-term consequences of sustained dual receptor stimulation. Published trial summaries should be consulted for exact measurements rather than secondary accounts.
Tirzepatide is a synthetic peptide built from 39 amino acid residues. Its backbone derives from the native glucose-dependent insulinotropic polypeptide sequence, altered at several positions to resist enzymatic cleavage. A fatty diacid group attached through a linker extends plasma residence time by promoting reversible binding to serum albumin. The molecule carries a net negative charge near physiological pH and has a reported molecular weight close to 4813 daltons. These features separate it from shorter incretin analogs and account for its prolonged dosing interval.
| Property | Value | Notes |
|---|---|---|
| Molecular class | Synthetic peptide | Dual incretin receptor agonist |
| Amino acid count | 39 residues | Includes non-natural residues |
| Approximate mass | 4.8 kDa | Reported values vary slightly by source |
| Fatty acid component | C20 diacid | Supports albumin binding |
| First US approval | 2022 | Glycemic indication, weight management followed |
The peptide shares degradation routes common to modified peptides: deamidation of asparagine and glutamine residues, oxidation of methionine, and backbone hydrolysis under extreme pH. Lyophilized material is generally more stable than a solution, and residual water content directly affects the rate of hydrolysis. In liquid form, aggregation and visible particles can appear after agitation or repeated freeze-thaw cycles. Stability studies therefore track monomer content, aggregate content, and potency over months under defined temperature and humidity.
Cold-chain handling is standard for formulated product, with dry powder stored frozen and ready-to-use solutions refrigerated. Light exposure is minimized because photodegradation of certain amino acid side chains is possible. Shipping and temperature-excursion studies are used to establish whether short deviations affect quality attributes. Documentation supplied with research material usually includes a certificate of analysis listing purity, identity confirmation, and water or residual solvent content. Users are expected to confirm that material meets the stated specification before use.
Bulk peptide material is normally characterised by reversed-phase high-performance liquid chromatography, which separates the target sequence from truncation products and other closely related impurities. Ultraviolet detection near 214 nanometres is common because the peptide backbone absorbs in that region. Mass spectrometry, usually electrospray ionisation coupled to a mass analyser, is used to confirm the molecular mass. Because the molecule carries a lipophilic side chain, gradient methods often need a relatively high organic modifier fraction to elute it within a practical retention window.
Like most synthetic peptides of this size, the material is commonly supplied as a lyophilised powder that appears white to off-white. It dissolves in aqueous buffers and in mixtures of water with a small proportion of organic solvent, though the fatty acid portion reduces solubility in pure water relative to short peptides. Hygroscopic behaviour is reported for many peptide powders, so weighing is usually performed quickly and under controlled humidity. Working solutions are typically prepared fresh and kept cold.
溶解操作一般使用注射用水或适宜的水性缓冲液，必要时加入少量助溶剂以改善溶解速度，但应避免剧烈涡旋振荡，因为剪切力可能促进聚集。配制后的溶液在冷藏条件下的稳定时间通常短于固体形态，具体时限取决于浓度、缓冲体系与容器材质。是否加入防腐成分，则取决于用途是否为多次取样。
定量分析的主流方法是反相高效液相色谱联用紫外或质谱检测，利用肽在疏水固定相上的保留行为确定纯度与含量。对于生物基质中的浓度测定，常采用液相色谱串联质谱，并配合固相萃取或蛋白沉淀进行样品前处理。免疫分析法也可使用，但可能受到结构相关肽的交叉反应干扰。
纯度评估通常综合反相色谱、体积排阻色谱与质谱三方面信息：前者反映疏水性杂质，后者反映聚集体，质谱则确认分子量与主要降解产物。有关降解途径的完整图谱——例如脱酰胺、氧化与水解各占多大比例——在不同储存条件下仍有差异，属于需要逐案验证的问题。
=== Spinal puncture === Following spinal anesthesia or puncture, people who are being treated with anti-thrombotic agents are at higher risk for developing a hematoma, which causes long-term or permanent paralysis. The risk of this may be increased by using epidural or intrathecal catheters after a surgical operation or from the concurrent use of medicinal agents that affect hemostasis.
Even the Chilean and Río de la Plata governments mistrusted Bolívar, accusing him of not letting each people decide their future. Bolívar's attitude contributed to accentuate this negative climate. He was irritable and reacted violently to the slightest contradiction. His egomania, already great, increased in those days to unimaginable levels when he had territories from the Venezuelan Caribbean to the Bolivian altiplano under his control. According to a diplomatic source from the United States, in 1826, during the celebration of his birthday, Bolívar stated at a banquet in his honor that he was "the greatest man of all those recorded in history, and that not only the heroes of antiquity were inferior to him in liberal ideas, but also Washington and Napoleon had lagged behind." He also used to do various eccentricities, such as suddenly stopping on the table and kicking bottles and glasses, as if to indicate that he could do whatever he wanted in Peru. In addition, in 1828, when the Peruvians entered Bolivia and After Sucre was deposed, Bolívar sought to create a "Bogotá-Rio de Janeiro axis" abandoning his previous attempts to isolate the Brazilian monarchy to achieve an anti-Peruvian coalition. It was a failure due to Colombian political instability and the geographical distances between its centers of power.
Quality Management Development of new strategies for performance appraisal of hospital, out-patient clinics and laboratories. Development of quality-based documentation, database and communication systems or technical and administrative tools at TBRI. Development of quality-based safety systems for patients, personnel and utilized tools at TBRI, and upgrading of human capacity. In 2025, the Institute has over 3,000 researchers, mainly in the areas of cancer and infectious diseases.
Thioesters are common intermediates in many biosynthetic reactions, including the formation and degradation of fatty acids and mevalonate, precursor to steroids. Examples include malonyl-CoA, acetoacetyl-CoA, propionyl-CoA, cinnamoyl-CoA, and acyl carrier protein (ACP) thioesters. Acetogenesis proceeds via the formation of acetyl-CoA. The biosynthesis of lignin, which comprises a large fraction of the Earth's land biomass, proceeds via a thioester derivative of caffeic acid. These thioesters arise analogously to those prepared synthetically, the difference being that the dehydration agent is ATP. In addition, thioesters play an important role in the tagging of proteins with ubiquitin, which tags the protein for degradation. Oxidation of the sulfur atom in thioesters (thiolactones) is postulated in the bioactivation of the antithrombotic prodrugs ticlopidine, clopidogrel, and prasugrel.
=== Pseudoelasticity === Even though soft tissues have viscoelastic properties, i.e. stress as function of strain rate, it can be approximated by a hyperelastic model after precondition to a load pattern. After some cycles of loading and unloading the material, the mechanical response becomes independent of strain rate.
Sources: en.wikipedia.org
== Cause == Scurvy, including subclinical scurvy, is caused by a deficiency of dietary vitamin C since the human liver is unable to synthesize vitamin C. Provided the diet contains sufficient vitamin C, the lack of working L-gulonolactone oxidase (GULO) enzyme has no significance. In modern Western societies, scurvy is seldom present in average adults, although underfed people (drug users, the homeless, neglected children and geriatrics) are affected. Virtually all commercially available baby formulas contain added vitamin C, preventing infantile scurvy. Human breast milk contains sufficient vitamin C if the mother has an adequate intake. Commercial milk is pasteurized, a heating process that destroys the natural vitamin C content of the milk. Scurvy is one of the accompanying diseases of malnutrition (other such micronutrient deficiencies are beriberi and pellagra) and thus is still widespread in areas of the world dependent on external food aid. Although rare, there are also documented cases of scurvy due to poor dietary choices by people living in industrialized nations.
== Bromine-77 == Bromine-77 is the most stable radioisotope of bromine, with a half-life of 57.04 hours. Although β+ decay is possible for this isotope, about 99.3% of decays are by electron capture. Despite its complex emission spectrum, featuring strong gamma-ray emissions at 239, 297, 521, and 579 keV, 77Br was used in SPECT imaging in the 1970s. However, except for longer-term tracing, this is no longer considered practical due to the difficult collimator requirements and the proximity of the 521 keV line to the 511 keV annihilation radiation related to the β+ decay. The Auger electrons emitted during decay are nevertheless well-suited for radiotherapy, and 77Br can possibly be paired with the imaging-suited 76Br (produced as an impurity in common synthesis routes) for this application.
== Deployment history == Georgia strongly supported the U.S.-led entrance of troops in Iraq for peacekeeping purposes and deployed troops to the country in August 2003. Georgia's military deployment was undertaken as part of broader efforts to bolster closer ties with the United States and NATO in the face of the continuing Russian threat. The United States provided military training programs—GTEP and GSSOP—for Georgian forces. There was no tangible domestic opposition to the Georgian involvement in Iraq. Georgia's initial deployment was a platoon of special forces and a medical team, a total of 70 personnel in 2003. The Georgian presence in Iraq increased to 300 personnel in 2004 and to 850 in 2005, and peaked at 2,300 soldiers in mid-2008. The largest contingents deployed were the 3rd Infantry Brigade (July 2007 – January 2008) and the 1st Infantry Brigade (January–August 2008). In addition to participation in Operation Iraqi Freedom, from 2005 to 2008 Georgia also contributed a battalion of approximately 550 troops to the United Nations Assistance Mission in Iraq, which was stationed in Baghdad within the "Green Zone". At first, the Georgian troops deployed for Operation Iraqi Freedom were stationed in Baghdad and provided general security measures. Beginning in 2007, the Georgians were deployed along the border with Iran, with their main base at Kut, and tasked to interdict smuggled weapons, goods, and drugs. The Georgian units worked primarily within the U.S. area of operations.
(2026) review different models of evolution of European hominins during the Middle Pleistocene (including evolutionary models including all European population in the lineage ancestral to Neanderthals and the models proposing coexistence of multiple contemporaneous lineages in Europe) and the analytical frameworks supporting these models. García-Martínez et al. (2026) report the discovery of a parietal bone from a new paleoanthropological site Ruidera (Spain), providing evidence of variability of cranial morphology of Middle Pleistocene hominins. Yue et al. (2026) report evidence of production of diverse stone tools at the Xigou site (Henan, China) between 160,000 and 72,000 years ago, including evidence of well-organised core reduction strategies, production of diverse small flake-based tools, and hafted implements. The earliest evidence of use of sophisticated, systematic centripetal flaking systems in eastern Asia known to date is reported from the late Middle Pleistocene Lingjing site (Henan, China) by Zhao et al. (2026). Siemssen et al. (2026) report evidence of antibacterial properties of birch tar produced with methods used in Europe during the Middle Paleolithic. Guil-Guerrero (2026) argues that consumption of fly larvae by Neanderthals postulated by Beasley, Lesnik & Speth (2025) does not by itself explain nitrogen isotope enrichment observed in Neanderthal collagen, interpreted as more likely to be primarily caused by targeted hunting and consumption of megafauna by Neanderthals.
Sources: en.wikipedia.org
It activates both the glucose-dependent insulinotropic polypeptide receptor and the glucagon-like peptide-1 receptor. This dual activity separates it from agents that act on only one of the two receptors. The relative contribution of each receptor to clinical effects remains an open area of study.
United States approval for type 2 diabetes was granted in 2022, and a chronic weight management indication was added later. Approval timelines differ across other jurisdictions. Earlier human data came from phase 1 and phase 2 trials published before those decisions.
Native hormones are short-lived peptides that enzymes degrade within minutes. Tirzepatide carries non-natural residues and a fatty acid chain that resist this breakdown and extend circulation time. The result is a longer interval between administrations than the natural hormones could support.
It is a synthetic peptide that activates both the GIP and GLP-1 receptors, making it a dual agonist. Approved products are given by injection rather than by mouth. It is not a small molecule and does not belong to the older sulfonylurea or thiazolidinedione families.